drugset / Trial / NCT04258007
Sugammadex Versus Neostigmine in Pediatric Less Than Two Years Undergoing Cardiac Catheterization
RandomizedParallel-groupDouble-blindTreatment
Summary
This study hypothesizes that Sugammadex may has more appropriate recovery profile than neostigmine in pediatric cardiac patients undergoing cardiac catheterization. In pediatric cardiac patients, clear and rapid recovery (fast-tracking) is required to maintain hemodynamic within the normal physiological values which may be saved by sugammadex
Timeline
- Start
- 2020-01-27
- Primary completion
- 2020-11-10
- Completion
- 2020-11-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Neostigmine | Other / unclassified | 0.04 mg/kg | — |
| Comparator | Sugammadex | Other / unclassified | 4 mg/kg | — |
| Comparator | Atropine | Other / unclassified | 0.02 mg/kg | — |
Indications
No indication recorded.